Aradigm
HomeAboutProductsTechnologiesInvestorsCareers
Download Library

Investor Relations

Press Releases

Events & Presentations

Scientific Publications

Corporate Governance

Financial Information

Stock Information

Contact Us


Quickly sort and find the exact file you need here. Send the files directly into your Shareholder Briefcase or read and right click "save target as" individual files.

Title Date Type Size  
2017 ERS Conference: Reduction in Frequency of Pulmonary Exacerbations With Inhaled ARD-3150 in Non-Cystic Fibrosis Bronchiectasis (NCFB) Patients is Independent of Pseudomonas aeruginosa Susceptibility at Baseline   PDF 468.9 KB Add to Briefcase
2017 World BE Conference Healthcare Cost and Utilization Before After Diagnosis Pseudomonas Aeruginosa Among Patients with Non Aeruginosa Among Patients with Non -cystic Fibrosis Bronchiectasis in the U.S.   PDF 348.5 KB Add to Briefcase
2017 World BE Conference The Prevalence of Non -cystic Fibrosis Bronchiectasis in the U.S.   PDF 274.6 KB Add to Briefcase
2017 World BE Conference Treatment Patterns Associated with Pseudomonas Aeruginosa Among Patients with Non Patients with Non -cystic Fibrosis Bronchiectasis in the U.S.   PDF 207.3 KB Add to Briefcase
2017 World BE Conference Inhaled Liposomal Ciprofloxacin in Patients With Non-Cystic Fibrosis Bronchiectasis and Chronic Pseudomonas aeruginosa Infection: Pharmacokinetics of Once-Daily Inhaled ARD-3150   PDF 554.9 KB Add to Briefcase
2017 ISAM Conference Inhaled Liposomal Ciprofloxacin for the Prevention and Treatment of Severe Intracellular Lung Infections   PDF 788.6 KB Add to Briefcase
2017 World BE Conference Microbiological Results From Two Parallel, Randomized, Double-blind, Placebo-Controlled Phase III Trials (ORBIT-3 and ORBIT-4) of the Inhaled Antibiotic ARD-3150 in Patients With Non-Cystic Fibrosis Bronchiectasis and Chronic Pseudomonas aeruginosa Infection   PDF 2.7 MB Add to Briefcase
2017 ISAM Conference Inhaled Liposomal Ciprofloxacin in Patients With Non-cystic Fibrosis Bronchiectasis and Chronic Pseudomonas aeruginosa Lung Infection   PDF 233.8 KB Add to Briefcase
2017 World BE Conference Inhaled Liposomal Ciprofloxacin in Patients With Bronchiectasis and Chronic Pseudomonas aeruginosa Infection: Results From Two Parallel Phase III Trials (ORBIT-3 and ORBIT-4)   PDF 232.7 KB Add to Briefcase
2015 Annual Report   HTML file N/A  
Showing 1-10 of 32 Page: 1 2 3 4  Next 10
Add to Briefcase = add file to Briefcase
CONTACT NEWS & EVENTS LEGAL SITE MAP ©2017 Aradigm Corporation. All Rights Reserved.